ReviewPancreas2022

Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Time for a Personalized Approach?

Amanda Puleo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.